









Markets
/
Stocks
/
nasdaq-valn
/

Valneva SE

VALN

View Detailed Chart

6.490USD

+0.040+0.62%

Close 07/16, 16:00（ET）Quotes delayed by 15 min

1.05BMarket Cap

LossP/E TTM



Valneva SE

6.490

+0.040+0.62%

Overview Company Financials

Financials

Intraday

30m

Today

+0.62%

5 Days

+10.09%

1 Month

+6.92%

6 Months

+50.58%

Year to Date

+48.44%

1 Year

-13.64%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 4 analysts

BUY

Current Rating

14.275

Target Price

121.32%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

554

Total

Median

Average

Company name

Ratings

Analysts

Valneva SE

VALN

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Exact Sciences Corp

EXAS

Ionis Pharmaceuticals Inc

IONS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(2)

Neutral(3)

Buy(6)

Indicators

Sell(1)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.206

Neutral

RSI(14)

67.587

Neutral

STOCH(KDJ)(9,3,3)

73.432

Neutral

ATR(14)

0.320

High Vlolatility

CCI(14)

181.829

Buy

Williams %R

19.773

Overbought

TRIX(12,20)

-0.030

Sell

StochRSI(14)

100.000

Overbought

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

6.220

Buy

MA10

6.019

Buy

MA20

5.852

Buy

MA50

6.131

Buy

MA100

6.500

Sell

MA200

5.849

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The Company has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The Company is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.

Ticker SymbolVALN

CompanyValneva SE

CEOMr. Thomas Lingelbach

Websitehttps://valneva.com/